Molecular Correlates of Early Onset of Diabetic Cardiomyopathy: Possible Therapeutic Targets
Author(s) -
Dongjuan Wang,
Kun Liu,
Jinyan Zhong,
Xin Li,
Jie Zhang,
Gongxin Wang,
Ni Li,
Tianwen Li,
Harvey Davis,
Ibrahim El-gaby,
Guoliang Hao,
Honghua Ye,
Dan Li
Publication year - 2022
Publication title -
oxidative medicine and cellular longevity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.494
H-Index - 93
eISSN - 1942-0900
pISSN - 1942-0994
DOI - 10.1155/2022/9014155
Subject(s) - diabetic cardiomyopathy , insulin resistance , cardiomyopathy , transcriptome , diabetes mellitus , oxidative stress , induced pluripotent stem cell , phenotype , biology , medicine , cardiac function curve , endocrinology , lipotoxicity , streptozotocin , mitochondrion , bioinformatics , cancer research , microbiology and biotechnology , heart failure , gene , gene expression , genetics , embryonic stem cell
Diabetes mellitus (DM) is associated with mitochondrial dysfunction and oxidative stress that can lead to diabetic cardiomyopathy (DCM), which can often remain undetected until late stages of the disease. However, myocardial injury occurs before the onset of measurable cardiac dysfunction, although its molecular correlates are poorly understood. In this study, we made a DM rat induced by a high-fat diet combined with low and high doses of streptozotocin (STZ) to emulate pre and early DCM. RNA-sequencing analysis of ventricular tissue revealed a differential transcriptome profile and abnormal activation of pathways involved in fatty acid metabolism, oxidative phosphorylation, cardiac structure and function, insulin resistance, calcium signalling, apoptosis, and TNF signalling. Moreover, using high glucose-treated human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM), we recapitulated the cardiac cellular phenotype of DM and identified several molecular correlates that may promote the development of DCM. In conclusion, we have developed an experimental framework to target pathways underlying the progression of DCM.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom